 |
|
|
 |
Drug Treatment Of Lead-Exposed Children Does Not Improve Psychological Test Scores
Using a lead-lowering drug to reverse the IQ damage associated with the lead exposure has proved ineffective, the National Institute of Environmental Health Sciences announced today. more
|
|
New Research Suggests Cause Of Autism
Autism -- a poorly understood genetic disorder present in more than a half million Americans -- may be caused by a defect in metal metabolism that impairs the development of the brain and can result in hypersensitivity to toxic environmental substances. In a study of 503 autism patients, 99 percent exhibited evidence of this metabolic disorder, according to information presented here today at the annual meeting of the American Psychiatric Association. more
|
|
|
|
Investigational Alzheimer's Drug Shows Promise
Data demonstrating the novel neuroprotective effects and clinical potential of memantine, an investigational new drug being developed in the United States as a treatment for Alzheimer's disease, were presented today at the clinical conferences of the American Psychiatric Association (APA) and the American Academy of Neurology (AAN). more
|
|
Some Multiple Sclerosis Patients May Benefit From Double-Drug Therapy
People with the most common types of multiple sclerosis who don't respond to traditional therapy may benefit from a combination drug therapy, a Wake Forest University Baptist Medical Center (WFUBMC) researcher reported today at the annual meeting of the American Academy of Neurology in Philadelphia, Penn. more
|
|
FDA Issues Health Advisory Regarding The Safety Of Sporanox Products And Lamisil Tablets To Treat Fungal Nail Infections
The Food and Drug Administration (FDA) today issued a Public Health Advisory to announce significant safety-related updates to the labeling of Sporanox® products and Lamisil® tablets. Sporanox® and Lamisil® are used to treat nail (onychomycosis), skin and other systemic fungal infections. The following may be used to answer questions. more
|
|
|
